We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRNA
1076
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4K ﹤0.01%
141
ALEC icon
1077
Alector
ALEC
$169M
$3K ﹤0.01%
149
ARQT icon
1078
Arcutis Biotherapeutics
ARQT
$3.55B
$3K ﹤0.01%
99
+17
+21% +$531
AUPH icon
1079
Aurinia Pharmaceuticals
AUPH
$1.92B
$3K ﹤0.01%
238
BCRX icon
1080
BioCryst Pharmaceuticals
BCRX
$2.48B
$3K ﹤0.01%
332
CDXS icon
1081
Codexis
CDXS
$136M
$3K ﹤0.01%
111
CSTL icon
1082
Castle Biosciences
CSTL
$725M
$3K ﹤0.01%
48
+11
+30% +$827
CYTK icon
1083
Cytokinetics
CYTK
$10.8B
$3K ﹤0.01%
133
GBIO
1084
DELISTED
Generation Bio
GBIO
$3K ﹤0.01%
11
+2
+22% +$640
GMAB icon
1085
Genmab
GMAB
$17.8B
$3K ﹤0.01%
86
HCM icon
1086
HUTCHMED
HCM
$1.93B
$3K ﹤0.01%
97
IMVT icon
1087
Immunovant
IMVT
$7.99B
$3K ﹤0.01%
184
IRWD icon
1088
Ironwood Pharmaceuticals
IRWD
$626M
$3K ﹤0.01%
301
KROS icon
1089
Keros Therapeutics
KROS
$199M
$3K ﹤0.01%
44
KRYS icon
1090
Krystal Biotech
KRYS
$10.7B
$3K ﹤0.01%
43
+6
+16% +$436
MDGL icon
1091
Madrigal Pharmaceuticals
MDGL
$12.4B
$3K ﹤0.01%
29
MGNX icon
1092
MacroGenics
MGNX
$245M
$3K ﹤0.01%
106
PGEN icon
1093
Precigen
PGEN
$1.97B
$3K ﹤0.01%
401
-96,148
-100% -$813K
PLRX icon
1094
Pliant Therapeutics
PLRX
$66.3M
$3K ﹤0.01%
67
QURE icon
1095
uniQure
QURE
$2.52B
$3K ﹤0.01%
84
REPL icon
1096
Replimune Group
REPL
$449M
$3K ﹤0.01%
86
RGNX icon
1097
Regenxbio
RGNX
$615M
$3K ﹤0.01%
84
+14
+20% +$597
SGMO
1098
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3K ﹤0.01%
266
SRRK icon
1099
Scholar Rock
SRRK
$5.92B
$3K ﹤0.01%
63
STOK icon
1100
Stoke Therapeutics
STOK
$1.83B
$3K ﹤0.01%
68

Similar funds

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.